Tag: ABX464
The phase III study is launched in the United States for ABX464
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
Abivax announces excellent efficacy and safety results after one year of treatment in the phase 2b maintenance study of ABX464 in ulcerative colitis. – 04/06/2022 at 6:05 p.m.
ABIVAX press release Abivax announces excellent efficacy and safety results after one year of treatment in the phase 2b maintenance study of ABX464 in ulcerative colitis. The interim analysis shows…
Abivax: excellent results in a phase 2b study for ABX464 – 04/06/2022 at 18:12
(AOF) – Good news for Abivax. The company announced on Wednesday evening excellent efficacy and safety results after one year of treatment in the phase 2b maintenance study of ABX464…